Literature DB >> 33134030

Bile Duct Injury due to Drug Induced Liver Injury.

Priya Grewal1, Jawad Ahmad1.   

Abstract

PURPOSE OF REVIEW-: Drug-induced liver injury (DILI) can present with a variable clinical and pathological phenotype and can be classified using liver enzymes as hepatocellular, cholestatic or a mixed pattern. The cholestatic pattern has been considered amongst the spectrum of direct liver damage at the microscopic level, but recently bile duct injury as a manifestation of DILI has emerged as a distinct entity and this review examines several examples of biliary tract abnormalities due to DILI from a clinical, radiologic and pathologic perspective. RECENT FINDINGS-: Case series and reports have emerged over the last few years of drugs causing cholangiographic changes or direct injury to the intra-and extra-hepatic biliary tree, such as ketamine and several chemotherapy agents. The DILI Network (DILIN) in the United States has published their experience of cases with vanishing bile duct syndrome on histology and sclerosing cholangitis like changes seen on cholangiography. The pathogenesis of these changes is unclear but it appears that this type of injury is more severe and more likely to lead to a chronic injury with increased mortality than other cases of DILI. SUMMARY-: Bile duct injury due to DILI is an increasingly recognized entity and imaging of the biliary tree in conjunction with liver biopsy should be considered in patients with severe cholestatic DILI.

Entities:  

Keywords:  Cholangitis; Drug-induced liver injury (DILI)

Year:  2019        PMID: 33134030      PMCID: PMC7597665          DOI: 10.1007/s11901-019-00474-0

Source DB:  PubMed          Journal:  Curr Hepatol Rep        ISSN: 2195-9595


  21 in total

1.  Nonsteroidal anti-inflammatory drug-induced vanishing bile duct syndrome treated with plasmapheresis.

Authors:  Yu Kawasaki; Kousaku Matsubara; Kimio Hashimoto; Ken Tanigawa; Masayoshi Kage; Aya Iwata; Hiroyuki Nigami; Takashi Fukaya
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-11       Impact factor: 2.839

2.  Ketamine abuse, biliary tract disease, and secondary sclerosing cholangitis.

Authors:  Aaron Turkish; Jean J Luo; Jay H Lefkowitch
Journal:  Hepatology       Date:  2013-08       Impact factor: 17.425

3.  Biochemical studies on bile duct epithelial cells isolated from rat liver.

Authors:  M Parola; K H Cheeseman; M E Biocca; M U Dianzani; T F Slater
Journal:  J Hepatol       Date:  1990-05       Impact factor: 25.083

4.  Ketamine-induced cholangiopathy: a case report.

Authors:  Wai-Kay Seto; Matthew Ng; Pierre Chan; Irene Oi-Lin Ng; Stephen Chi-Wai Cheung; Ivan Fan-Ngai Hung; Man-Fung Yuen; Ching-Lung Lai
Journal:  Am J Gastroenterol       Date:  2011-05       Impact factor: 10.864

Review 5.  Drug-induced vanishing bile duct syndrome: response to ursodiol.

Authors:  C B O'Brien; D S Shields; S H Saul; K R Reddy
Journal:  Am J Gastroenterol       Date:  1996-07       Impact factor: 10.864

Review 6.  Risk factors for idiosyncratic drug-induced liver injury.

Authors:  Naga Chalasani; Einar Björnsson
Journal:  Gastroenterology       Date:  2010-04-12       Impact factor: 22.682

7.  Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

Authors:  Naga Chalasani; Herbert L Bonkovsky; Robert Fontana; William Lee; Andrew Stolz; Jayant Talwalkar; K Rajendar Reddy; Paul B Watkins; Victor Navarro; Huiman Barnhart; Jiezhun Gu; Jose Serrano
Journal:  Gastroenterology       Date:  2015-03-06       Impact factor: 22.682

8.  ACR appropriateness criteria jaundice.

Authors:  Tasneem Lalani; Corey A Couto; Max P Rosen; Mark E Baker; Michael A Blake; Brooks D Cash; Jeff L Fidler; Frederick L Greene; Nicole M Hindman; Douglas S Katz; Harmeet Kaur; Frank H Miller; Aliya Qayyum; William C Small; Gary S Sudakoff; Vahid Yaghmai; Gail M Yarmish; Judy Yee
Journal:  J Am Coll Radiol       Date:  2013-04-28       Impact factor: 5.532

9.  Liver injury is common among chronic abusers of ketamine.

Authors:  Grace Lai-Hung Wong; Yuk-Him Tam; Chi-Fai Ng; Anthony Wing-Hung Chan; Paul Cheung-Lung Choi; Winnie Chiu-Wing Chu; Paul Bo-San Lai; Henry Lik-Yuen Chan; Vincent Wai-Sun Wong
Journal:  Clin Gastroenterol Hepatol       Date:  2014-02-15       Impact factor: 11.382

10.  Sclerosing Cholangitis-Like Changes on Magnetic Resonance Cholangiography in Patients With Drug Induced Liver Injury.

Authors:  Jawad Ahmad; Simona Rossi; Shuchi K Rodgers; Marwan Ghabril; Robert J Fontana; Andrew Stolz; Paul H Hayashi; Huiman Barnhart; David E Kleiner; Einar S Bjornsson
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-30       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.